Is the US7 score sensitive to change in a large cohort of patients with rheumatoid arthritis over 12 months of therapy?
The comparable developments of the US7 score with clinical and laboratory data illustrates its potential to reflect therapeutic response. Therefore, the novel US7 score is sensitive to change. Patients who switched from one biologic to another exhibited a significant decline in erosions after 12 months, while the erosions scores in the other groups were stable.
Our study results show that preoperative air travel do not further increase the risk of VTE after TKA and THA.